
Stem cell and drug discovery research company supplying iPSC tools, human tissue testing and clinical services

Early-stage venture capital firm backing deep technology founders in Israel, Europe and the United States

Cardumen Capital is an early-stage venture capital firm that backs technology founders. Its general partners are investors, founders and operators, and they have spent more than a decade building and selling technology companies in Israel, Europe and the United States.
The firm focuses on artificial intelligence, cybersecurity and big data, including analytics, databases and data management. It invests in both software and hardware, specialising in B2B and B2B2C products. It also considers strong consumer teams, although that is outside its comfort zone.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images — click to enlarge
As of 2026-10-05. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Cardumen Capital.
Similar listings buyers compare against this one.

Stem cell and drug discovery research company supplying iPSC tools, human tissue testing and clinical services

Midwest venture capital firm investing in early-stage healthcare companies, from diagnostics to life science tools

Turismo Capital

Investment platform giving accredited investors access to curated space-industry deals and portfolio tools

University entrepreneurship hub helping UCI students develop and start their own businesses

Deep tech venture fund backing patent-based science startups in the US Southwest and Northern Europe
Everything here links back to the same verified catalogue. Pick your next stop.